vs
PAR TECHNOLOGY CORP(PAR)与Ultragenyx Pharmaceutical Inc.(RARE)财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是PAR TECHNOLOGY CORP的1.7倍($207.3M vs $120.1M),Ultragenyx Pharmaceutical Inc.同比增速更快(25.9% vs 14.4%),PAR TECHNOLOGY CORP自由现金流更多($-12.5M vs $-100.8M),过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高(38.0% vs 30.9%)
PAR科技公司是全球领先的销售点系统、餐饮酒店管理软件及集成技术解决方案提供商,核心业务覆盖餐饮服务、酒店文旅及政府安防领域,为各类规模客户提供云端工具以简化运营、提升消费体验与经营效率。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业,专注于研发罕见病和超罕见遗传病的创新治疗方案,这类疾病目前大多无获批疗法,存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台,研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PAR vs RARE — 直观对比
营收规模更大
RARE
是对方的1.7倍
$120.1M
营收增速更快
RARE
高出11.5%
14.4%
自由现金流更多
PAR
多$88.2M
$-100.8M
两年增速更快
RARE
近两年复合增速
30.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $120.1M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | 41.2% | — |
| 营业利润率 | -15.0% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 14.4% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益(稀释后) | $-0.52 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PAR
RARE
| Q4 25 | $120.1M | $207.3M | ||
| Q3 25 | $119.2M | $159.9M | ||
| Q2 25 | $112.4M | $166.5M | ||
| Q1 25 | $103.9M | $139.3M | ||
| Q4 24 | $105.0M | $164.6M | ||
| Q3 24 | $96.8M | $139.5M | ||
| Q2 24 | $78.2M | $147.0M | ||
| Q1 24 | $70.1M | $108.8M |
净利润
PAR
RARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $-18.2M | $-180.4M | ||
| Q2 25 | $-21.0M | $-115.0M | ||
| Q1 25 | $-24.4M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $-19.8M | $-133.5M | ||
| Q2 24 | $54.2M | $-131.6M | ||
| Q1 24 | $-18.3M | $-170.7M |
毛利率
PAR
RARE
| Q4 25 | 41.2% | — | ||
| Q3 25 | 41.3% | — | ||
| Q2 25 | 45.4% | — | ||
| Q1 25 | 46.5% | — | ||
| Q4 24 | 42.9% | — | ||
| Q3 24 | 44.5% | — | ||
| Q2 24 | 41.0% | — | ||
| Q1 24 | 37.2% | — |
营业利润率
PAR
RARE
| Q4 25 | -15.0% | -54.7% | ||
| Q3 25 | -14.8% | -106.9% | ||
| Q2 25 | -15.4% | -64.8% | ||
| Q1 25 | -15.2% | -102.6% | ||
| Q4 24 | -15.6% | -74.3% | ||
| Q3 24 | -15.7% | -94.6% | ||
| Q2 24 | -26.5% | -79.1% | ||
| Q1 24 | -38.2% | -151.9% |
净利率
PAR
RARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | -15.3% | -112.8% | ||
| Q2 25 | -18.7% | -69.0% | ||
| Q1 25 | -23.4% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | -20.5% | -95.7% | ||
| Q2 24 | 69.3% | -89.5% | ||
| Q1 24 | -26.1% | -156.8% |
每股收益(稀释后)
PAR
RARE
| Q4 25 | $-0.52 | $-1.28 | ||
| Q3 25 | $-0.45 | $-1.81 | ||
| Q2 25 | $-0.52 | $-1.17 | ||
| Q1 25 | $-0.60 | $-1.57 | ||
| Q4 24 | $-0.56 | $-1.34 | ||
| Q3 24 | $-0.56 | $-1.40 | ||
| Q2 24 | $1.60 | $-1.52 | ||
| Q1 24 | $-0.62 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $80.1M | $421.0M |
| 总债务越低越好 | $394.0M | — |
| 股东权益账面价值 | $825.1M | $-80.0M |
| 总资产 | $1.4B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势,按日历期对齐
现金及短期投资
PAR
RARE
| Q4 25 | $80.1M | $421.0M | ||
| Q3 25 | $93.0M | $202.5M | ||
| Q2 25 | $85.7M | $176.3M | ||
| Q1 25 | $92.2M | $127.1M | ||
| Q4 24 | $108.6M | $174.0M | ||
| Q3 24 | $118.4M | $150.6M | ||
| Q2 24 | $142.5M | $480.7M | ||
| Q1 24 | $72.5M | $112.3M |
总债务
PAR
RARE
| Q4 25 | $394.0M | — | ||
| Q3 25 | $393.4M | — | ||
| Q2 25 | $392.8M | — | ||
| Q1 25 | $392.3M | — | ||
| Q4 24 | $368.4M | — | ||
| Q3 24 | $466.7M | — | ||
| Q2 24 | $378.7M | — | ||
| Q1 24 | $378.2M | — |
股东权益
PAR
RARE
| Q4 25 | $825.1M | $-80.0M | ||
| Q3 25 | $838.0M | $9.2M | ||
| Q2 25 | $859.1M | $151.3M | ||
| Q1 25 | $852.0M | $144.2M | ||
| Q4 24 | $871.7M | $255.0M | ||
| Q3 24 | $692.7M | $346.8M | ||
| Q2 24 | $588.3M | $432.4M | ||
| Q1 24 | $526.4M | $140.3M |
总资产
PAR
RARE
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $1.0B | $1.3B |
负债/权益比
PAR
RARE
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.42× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.64× | — | ||
| Q1 24 | 0.72× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-11.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-12.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | -10.4% | -48.6% |
| 资本支出强度资本支出/营收 | 0.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-30.5M | $-472.0M |
8季度趋势,按日历期对齐
经营现金流
PAR
RARE
| Q4 25 | $-11.8M | $-99.8M | ||
| Q3 25 | $8.4M | $-91.4M | ||
| Q2 25 | $-6.6M | $-108.3M | ||
| Q1 25 | $-17.2M | $-166.5M | ||
| Q4 24 | $3.4M | $-79.3M | ||
| Q3 24 | $8.8M | $-67.0M | ||
| Q2 24 | $-13.8M | $-77.0M | ||
| Q1 24 | $-23.6M | $-190.7M |
自由现金流
PAR
RARE
| Q4 25 | $-12.5M | $-100.8M | ||
| Q3 25 | $7.0M | $-92.7M | ||
| Q2 25 | $-7.4M | $-110.7M | ||
| Q1 25 | $-17.6M | $-167.8M | ||
| Q4 24 | $3.2M | $-79.5M | ||
| Q3 24 | $8.4M | $-68.6M | ||
| Q2 24 | $-14.2M | $-79.0M | ||
| Q1 24 | $-23.6M | $-193.9M |
自由现金流率
PAR
RARE
| Q4 25 | -10.4% | -48.6% | ||
| Q3 25 | 5.9% | -58.0% | ||
| Q2 25 | -6.6% | -66.5% | ||
| Q1 25 | -16.9% | -120.5% | ||
| Q4 24 | 3.0% | -48.3% | ||
| Q3 24 | 8.7% | -49.2% | ||
| Q2 24 | -18.2% | -53.7% | ||
| Q1 24 | -33.7% | -178.2% |
资本支出强度
PAR
RARE
| Q4 25 | 0.7% | 0.5% | ||
| Q3 25 | 1.1% | 0.8% | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 0.4% | 1.0% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.5% | 1.4% | ||
| Q1 24 | 0.1% | 3.0% |
现金转化率
PAR
RARE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.26× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PAR
| Subscription Service | $76.1M | 63% |
| Hardware | $27.8M | 23% |
| Professional Service | $16.2M | 13% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |